SFS
CRBP icon

Sowell Financial Services’s Corbus Pharmaceuticals CRBP Stock Holding History

Sowell Financial Services’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-76
Closed -$4K – 965
2021
Q1 		$4K Sell
76
-1
-1% -$66 ﹤0.01% 2653
2020
Q4 		$3K Buy
77
+23
+43% +$860 ﹤0.01% 2386
2020
Q3 		$3K Sell
54
-1
-2% -$181 ﹤0.01% 2111
2020
Q2 		$14K Buy
55
+24
+77% +$4.85K ﹤0.01% 1568
2020
Q1 		$5K Hold
31
– – ﹤0.01% 1807
2019
Q4 		$5K Hold
31
– – ﹤0.01% 1893
2019
Q3 		$5K Buy
+31
New +$5.4K ﹤0.01% 1751

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Sowell Financial Services's CRBP Position: Q2 2021 in Review

Sowell Financial Services sold out of Corbus Pharmaceuticals (CRBP) in Q2 2021, closing a stake of 76 shares — an estimated $4K sold.

Sowell Financial Services first reported a position in CRBP in Q3 2019 and held it in 7 quarters. The position peaked at $14K in Q2 2020. 98 funds tracked by Wall St. Rank hold CRBP as of Q2 2021.

  • Sowell Financial Services reported no remaining Corbus Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 76 Corbus Pharmaceuticals shares in Q2 2021, an estimated $4K.
  • Sowell Financial Services first reported a position in Corbus Pharmaceuticals in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Corbus Pharmaceuticals position peaked at $14K in Q2 2020.
  • 98 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.